Frank Tufaro

Chief Operating Officer at Synthetic Biologics, Inc. - Rockville, MD, US

Frank Tufaro's Colleagues at Synthetic Biologics, Inc.
Vince Wacher

Contractor

Contact Vince Wacher

Mary Shallcross

Director of Clinical Operations

Contact Mary Shallcross

Andrew Bristol

Vice President, Development

Contact Andrew Bristol

Steve Hubert

Sr. Director of Manufacturing

Contact Steve Hubert

Michael Kaleko

Senior Vice President, Research and Development

Contact Michael Kaleko

Suzanne Sealing

Director of Accounting

Contact Suzanne Sealing

View All Frank Tufaro's Colleagues
Frank Tufaro's Contact Details
Email (Verified)
***@syntheticbiologics.com
Get Frank Tufaro's Email Address
Mobile Number
(XXX) XXX-XXXX
Get Frank Tufaro's Mobile Number
HQ
301-417-4364
Location
Rancho Santa Fe,California,United States
Company
Synthetic Biologics, Inc.
Frank Tufaro's Company Details
Synthetic Biologics, Inc. logo, Synthetic Biologics, Inc. contact details

Synthetic Biologics, Inc.

Rockville, MD, US • 20 - 49 Employees
BioTech/Drugs

Synthetic Biologics, Inc. (NYSE MKT: SYN) is a late-stage clinical company developing therapeutics designed to preserve the microbiome to protect and restore the health of patients. The Company's lead candidates poised for Phase 3 development are: (1) SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation (IBS-C), and (2) SYN-004 (ribaxamase) which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) beta-lactam antibiotics for the prevention of C. difficile infection (CDI), antibiotic-associated diarrhea (AAD) and the emergence of antimicrobial-resistance (AMR). The Company is also developing preclinical stage monoclonal antibody therapies for the prevention and treatment of pertussis and novel discovery stage biotherapeutics for the treatment of phenylketonuria (PKU).

Microbiome Prevention of C. dificile Infection Irritable Bowel Syndrome with Constipation (IBS-C) Clinical Development Drug discovery Preservation of natural gut microbiome B2B BioTech/Drugs Commercial Physical Research Biotechnology
Details about Synthetic Biologics, Inc.
Frequently Asked Questions about Frank Tufaro
Frank Tufaro currently works for Synthetic Biologics, Inc..
Frank Tufaro's role at Synthetic Biologics, Inc. is Chief Operating Officer.
Frank Tufaro's email address is ***@syntheticbiologics.com. To view Frank Tufaro's full email address, please signup to ConnectPlex.
Frank Tufaro works in the Research industry.
Frank Tufaro's colleagues at Synthetic Biologics, Inc. are Vince Wacher, Mary Shallcross, Andrew Bristol, Steve Hubert, Michael Kaleko, Suzanne Sealing and others.
Frank Tufaro's phone number is 301-417-4364
See more information about Frank Tufaro